Dupilumab efficacy and safety in patients with asthma and blood eosinophils =500 cells·µL-1
Klaus F. Rabe, Ian D. Pavord, Mario Castro, Michael E. Wechsler, Nadia Daizadeh, Upender Kapoor, Benjamin Ortiz, Amr Radwan, Robert R. Johnson, Paul J. Rowe, Yamo Deniz, Juby A. Jacob-Nara
Source: Eur Respir J, 59 (6) 2102577; 10.1183/13993003.02577-2021
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Klaus F. Rabe, Ian D. Pavord, Mario Castro, Michael E. Wechsler, Nadia Daizadeh, Upender Kapoor, Benjamin Ortiz, Amr Radwan, Robert R. Johnson, Paul J. Rowe, Yamo Deniz, Juby A. Jacob-Nara. Dupilumab efficacy and safety in patients with asthma and blood eosinophils =500 cells·µL-1. Eur Respir J, 59 (6) 2102577; 10.1183/13993003.02577-2021
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|